These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 15238457)

  • 1. In vivo magnetic resonance imaging of coronary thrombosis using a fibrin-binding molecular magnetic resonance contrast agent.
    Botnar RM; Buecker A; Wiethoff AJ; Parsons EC; Katoh M; Katsimaglis G; Weisskoff RM; Lauffer RB; Graham PB; Gunther RW; Manning WJ; Spuentrup E
    Circulation; 2004 Sep; 110(11):1463-6. PubMed ID: 15238457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular coronary MR imaging of human thrombi using EP-2104R, a fibrin-targeted contrast agent: experimental study in a swine model.
    Spuentrup E; Katoh M; Wiethoff AJ; Buecker A; Botnar RM; Parsons EC; Guenther RW
    Rofo; 2007 Nov; 179(11):1166-73. PubMed ID: 17948194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibility.
    Vymazal J; Spuentrup E; Cardenas-Molina G; Wiethoff AJ; Hartmann MG; Caravan P; Parsons EC
    Invest Radiol; 2009 Nov; 44(11):697-704. PubMed ID: 19809344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular MR imaging of human thrombi in a swine model of pulmonary embolism using a fibrin-specific contrast agent.
    Spuentrup E; Katoh M; Buecker A; Fausten B; Wiethoff AJ; Wildberger JE; Haage P; Parsons EC; Botnar RM; Graham PB; Vettelschoss M; Günther RW
    Invest Radiol; 2007 Aug; 42(8):586-95. PubMed ID: 17620942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic thrombus detection with in vivo magnetic resonance imaging and a fibrin-targeted contrast agent.
    Sirol M; Fuster V; Badimon JJ; Fallon JT; Moreno PR; Toussaint JF; Fayad ZA
    Circulation; 2005 Sep; 112(11):1594-600. PubMed ID: 16145001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular magnetic resonance imaging of atrial clots in a swine model.
    Spuentrup E; Fausten B; Kinzel S; Wiethoff AJ; Botnar RM; Graham PB; Haller S; Katoh M; Parsons EC; Manning WJ; Busch T; Günther RW; Buecker A
    Circulation; 2005 Jul; 112(3):396-9. PubMed ID: 16009790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular magnetic resonance imaging of myocardial perfusion with EP-3600, a collagen-specific contrast agent: initial feasibility study in a swine model.
    Spuentrup E; Ruhl KM; Botnar RM; Wiethoff AJ; Buhl A; Jacques V; Greenfield MT; Krombach GA; Günther RW; Vangel MG; Caravan P
    Circulation; 2009 Apr; 119(13):1768-75. PubMed ID: 19307474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular magnetic resonance imaging of coronary thrombosis and pulmonary emboli with a novel fibrin-targeted contrast agent.
    Spuentrup E; Buecker A; Katoh M; Wiethoff AJ; Parsons EC; Botnar RM; Weisskoff RM; Graham PB; Manning WJ; Günther RW
    Circulation; 2005 Mar; 111(11):1377-82. PubMed ID: 15738354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular magnetic resonance imaging of deep vein thrombosis using a fibrin-targeted contrast agent: a feasibility study.
    Katoh M; Haage P; Wiethoff AJ; Günther RW; Bücker A; Tacke J; Spuentrup E
    Invest Radiol; 2009 Mar; 44(3):146-50. PubMed ID: 19151606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EP-2104R: a fibrin-specific gadolinium-Based MRI contrast agent for detection of thrombus.
    Overoye-Chan K; Koerner S; Looby RJ; Kolodziej AF; Zech SG; Deng Q; Chasse JM; McMurry TJ; Caravan P
    J Am Chem Soc; 2008 May; 130(18):6025-39. PubMed ID: 18393503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular magnetic resonance imaging of pulmonary emboli with a fibrin-specific contrast agent.
    Spuentrup E; Katoh M; Wiethoff AJ; Parsons EC; Botnar RM; Mahnken AH; Günther RW; Buecker A
    Am J Respir Crit Care Med; 2005 Aug; 172(4):494-500. PubMed ID: 15937292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-time magnetic resonance imaging-guided coronary catheterization in swine.
    Omary RA; Green JD; Schirf BE; Li Y; Finn JP; Li D
    Circulation; 2003 Jun; 107(21):2656-9. PubMed ID: 12756160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gadocoletic acid trisodium salt (b22956/1): a new blood pool magnetic resonance contrast agent with application in coronary angiography.
    de Haën C; Anelli PL; Lorusso V; Morisetti A; Maggioni F; Zheng J; Uggeri F; Cavagna FM
    Invest Radiol; 2006 Mar; 41(3):279-91. PubMed ID: 16481911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MR angiography of the coronary arteries: comparison of the blood pool contrast medium Gadomer and Gd-DTPA in pigs].
    Schnorr J; Wagner S; Ebert W; Heyer C; Laub G; Kivelitz D; Abramjuk C; Hamm B; Taupitz M
    Rofo; 2003 Jun; 175(6):822-9. PubMed ID: 12811696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent.
    Botnar RM; Perez AS; Witte S; Wiethoff AJ; Laredo J; Hamilton J; Quist W; Parsons EC; Vaidya A; Kolodziej A; Barrett JA; Graham PB; Weisskoff RM; Manning WJ; Johnstone MT
    Circulation; 2004 Apr; 109(16):2023-9. PubMed ID: 15066940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracoronary injection of contrast media maps the territory of the coronary artery: an MRI technique for assessing the effects of locally delivered angiogenic therapies.
    Carlsson M; Saeed M
    Acad Radiol; 2008 Nov; 15(11):1354-9. PubMed ID: 18995187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artifact-free coronary magnetic resonance angiography and coronary vessel wall imaging in the presence of a new, metallic, coronary magnetic resonance imaging stent.
    Spuentrup E; Ruebben A; Mahnken A; Stuber M; Kölker C; Nguyen TH; Günther RW; Buecker A
    Circulation; 2005 Mar; 111(8):1019-26. PubMed ID: 15723984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular MRI of cerebral venous sinus thrombosis using a new fibrin-specific MR contrast agent.
    Stracke CP; Katoh M; Wiethoff AJ; Parsons EC; Spangenberg P; Spüntrup E
    Stroke; 2007 May; 38(5):1476-81. PubMed ID: 17379818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular imaging of factor XIIIa activity in thrombosis using a novel, near-infrared fluorescent contrast agent that covalently links to thrombi.
    Jaffer FA; Tung CH; Wykrzykowska JJ; Ho NH; Houng AK; Reed GL; Weissleder R
    Circulation; 2004 Jul; 110(2):170-6. PubMed ID: 15210587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo magnetic resonance imaging of atherosclerotic lesions with a newly developed Evans blue-DTPA-gadolinium contrast medium in apolipoprotein-E-deficient mice.
    Yasuda S; Ikuta K; Uwatoku T; Oi K; Abe K; Hyodo F; Yoshimitsu K; Sugimura K; Utsumi H; Katayama Y; Shimokawa H
    J Vasc Res; 2008; 45(2):123-8. PubMed ID: 17940339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.